203 related articles for article (PubMed ID: 26491690)
1. Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome.
Jensen LJ; Flyvbjerg A; Bjerre M
Biomed Res Int; 2015; 2015():815942. PubMed ID: 26491690
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
3. Elevated soluble receptor for advanced glycation end product levels in patients with acute coronary syndrome and positive cardiac troponin I.
Basta G; Del Turco S; Marchi F; Navarra T; Battaglia D; Mercuri A; Mazzone A; Berti S
Coron Artery Dis; 2011 Dec; 22(8):590-4. PubMed ID: 22072229
[TBL] [Abstract][Full Text] [Related]
4. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
[TBL] [Abstract][Full Text] [Related]
5. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
[TBL] [Abstract][Full Text] [Related]
6. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
[TBL] [Abstract][Full Text] [Related]
7. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
[TBL] [Abstract][Full Text] [Related]
8. The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.
Grauen Larsen H; Yndigegn T; Marinkovic G; Grufman H; Mares R; Nilsson J; Goncalves I; Schiopu A
Atherosclerosis; 2019 Aug; 287():16-23. PubMed ID: 31181415
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism.
Caspar-Bell G; Dhar I; Prasad K
Mol Cell Biochem; 2016 Mar; 414(1-2):171-8. PubMed ID: 26895319
[TBL] [Abstract][Full Text] [Related]
10. Soluble receptor for advanced glycation end products as a potential biomarker to predict weight loss and improvement of insulin sensitivity by a very low calorie diet of obese human subjects.
Hagen I; Schulte DM; Müller N; Martinsen J; Türk K; Hedderich J; Schreiber S; Laudes M
Cytokine; 2015 Jun; 73(2):265-9. PubMed ID: 25802195
[TBL] [Abstract][Full Text] [Related]
11. Circulating soluble receptor for advanced glycation end products is decreased and inversely associated with acute phase response in chronic spontaneous urticaria.
Kasperska-Zajac A; Damasiewicz-Bodzek A; Tyrpień-Golder K; Zamlyński J; Grzanka A
Inflamm Res; 2016 May; 65(5):343-6. PubMed ID: 26801062
[TBL] [Abstract][Full Text] [Related]
12. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
Mahajan N; Malik N; Bahl A; Dhawan V
Atherosclerosis; 2009 Dec; 207(2):597-602. PubMed ID: 19576587
[TBL] [Abstract][Full Text] [Related]
13. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.
Yu SL; Wong CK; Szeto CC; Li EK; Cai Z; Tam LS
Lupus; 2015 Jun; 24(7):675-86. PubMed ID: 25411258
[TBL] [Abstract][Full Text] [Related]
14. Dynamic changes in sRAGE levels and relationship with cardiac function in STEMI patients.
Jensen LJ; Lindberg S; Hoffmann S; Iversen AZ; Pedersen SH; Møgelvang R; Galatius S; Flyvbjerg A; Jensen JS; Bjerre M
Clin Biochem; 2015 Mar; 48(4-5):297-301. PubMed ID: 25562186
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome.
Raposeiras-Roubín S; Rodiño-Janeiro BK; Paradela-Dobarro B; Grigorian-Shamagian L; García-Acuña JM; Aguiar-Souto P; Jacquet-Hervet M; Reino-Maceiras MV; González-Juanatey JR; Álvarez E
PLoS One; 2013; 8(9):e74302. PubMed ID: 24058542
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
17. The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease.
Wang X; Xu T; Mungun D; Zhou C; Zha Z; Lu M; Fen C; Guo Y
Dis Markers; 2019; 2019():4528382. PubMed ID: 31275446
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of soluble receptor for advanced glycation end products and coronary atherosclerosis: possible correlation with clinical presentation.
Falcone C; Bozzini S; D'Angelo A; Matrone B; Colonna A; Benzi A; Paganini EM; Falcone R; Pelissero G
Dis Markers; 2013; 35(3):135-40. PubMed ID: 24167358
[TBL] [Abstract][Full Text] [Related]
19. Effects of a recruitment maneuver on plasma levels of soluble RAGE in patients with diffuse acute respiratory distress syndrome: a prospective randomized crossover study.
Jabaudon M; Hamroun N; Roszyk L; Guérin R; Bazin JE; Sapin V; Pereira B; Constantin JM
Intensive Care Med; 2015 May; 41(5):846-55. PubMed ID: 25792206
[TBL] [Abstract][Full Text] [Related]
20. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
